As of 2026-09-26, the Relative Valuation of Travere Therapeutics Inc (TVTX) is (11.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 59.44 USD, the upside of Travere Therapeutics Inc based on Relative Valuation is -119.1%.
The range of the Relative Valuation is (11.36) - (12.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.3x - 37.6x | 28.0x |
| Forward P/E multiples | 14.0x - 26.8x | 20.7x |
| Fair Price | (11.36) - (12.51) | (11.37) |
| Upside | -119.1% - -121.0% | -119.1% |
| Date | P/E |
| 2026-09-25 | -127.17 |
| 2026-09-24 | -129.69 |
| 2026-09-23 | -128.00 |
| 2026-09-22 | -128.97 |
| 2026-09-21 | -134.49 |
| 2026-09-18 | -134.27 |
| 2026-09-17 | -138.51 |
| 2026-09-16 | -135.81 |
| 2026-09-15 | -133.74 |
| 2026-09-14 | -140.76 |
| 2026-09-11 | -141.57 |
| 2026-09-10 | -144.44 |
| 2026-09-09 | -141.68 |
| 2026-09-08 | -141.35 |
| 2026-09-04 | -139.66 |
| 2026-09-03 | -142.36 |
| 2026-09-02 | -143.84 |
| 2026-09-01 | -140.58 |
| 2026-08-31 | -141.80 |
| 2026-08-28 | -140.50 |
| 2026-08-27 | -144.46 |
| 2026-08-26 | -143.60 |
| 2026-08-25 | -143.37 |
| 2026-08-24 | -139.54 |
| 2026-08-21 | -140.58 |
| 2026-08-20 | -137.91 |
| 2026-08-19 | -141.12 |
| 2026-08-18 | -136.71 |
| 2026-08-17 | -135.92 |
| 2026-08-14 | -132.95 |
| 2026-08-13 | -131.43 |
| 2026-08-12 | -132.99 |
| 2026-08-11 | -128.82 |
| 2026-08-10 | -130.27 |
| 2026-08-07 | -131.19 |
| 2026-08-06 | -133.61 |
| 2026-08-05 | -134.27 |
| 2026-08-04 | -119.85 |
| 2026-08-03 | -117.63 |
| 2026-07-31 | -119.58 |
| 2026-07-30 | -122.55 |
| 2026-07-29 | -118.87 |
| 2026-07-28 | -119.62 |
| 2026-07-27 | -121.27 |
| 2026-07-24 | -122.72 |
| 2026-07-23 | -121.27 |
| 2026-07-22 | -120.37 |
| 2026-07-21 | -121.05 |
| 2026-07-20 | -118.68 |
| 2026-07-17 | -121.33 |